Repros Therapeutics, Inc. (RPRX) Posts Narrower than Expected Q3 Loss

November 10, 2011 9:26 AM

Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q3 loss of ($0.32), $0.03 better than the analyst estimate of ($0.35).

No results found